These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8562654

  • 1. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
    Busygina OG, Belushkina NN, Grigor'ev NB, Severina IS.
    Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
    [Abstract] [Full Text] [Related]

  • 2. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS, Bussygina OG, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 4. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
    Belushkina NN, Grigor'ev NB, Severina IS.
    Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
    [Abstract] [Full Text] [Related]

  • 5. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS.
    Vopr Med Khim; 2002 Nov; 48(1):4-30. PubMed ID: 12068497
    [Abstract] [Full Text] [Related]

  • 6. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS.
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The role of SH-groups in guanidine thiols--new substrates for NO-synthase--in stimulating the activity of guanylate cyclase].
    Busygina OG, Grigor'ev NB, Severina IS.
    Biokhimiia; 1996 Jan; 61(1):119-25. PubMed ID: 8679771
    [Abstract] [Full Text] [Related]

  • 9. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

  • 10. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS.
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition of ADP-induced platelet aggregation by guanidine thiols--a novel class of guanylate cyclase activators and NO-synthase substrates].
    Belushkina NN, Severina IS.
    Biokhimiia; 1996 Dec; 61(12):2140-6. PubMed ID: 9156556
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of activation of soluble guanylate cyclase by guanidine thiols--a new class of enzyme activators.
    Severina IS, Bussygina OG, Vinograd LH, Grigoryev NB.
    Biochem Mol Biol Int; 1996 Mar; 38(3):509-18. PubMed ID: 8829610
    [Abstract] [Full Text] [Related]

  • 13. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS.
    Biull Eksp Biol Med; 1995 Mar; 119(3):230-5. PubMed ID: 7795182
    [No Abstract] [Full Text] [Related]

  • 14. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
    Riaposova IK, Grigor'ev NV, Severina IS.
    Biokhimiia; 1994 Apr; 59(4):537-42. PubMed ID: 7912551
    [Abstract] [Full Text] [Related]

  • 15. [Effect of N-(6-aminohexyl)-5-chloronaphthalene-1-sulfamide (W-7) and its analogs on the activity of soluble guanylate cyclase and on human platelet aggregation].
    Severina IS, Shirkov IuIu, Belushkina NN, Tyshchuk IA, Kulagin SV, Khropov IuV.
    Biokhimiia; 1990 Sep; 55(9):1717-24. PubMed ID: 1981851
    [Abstract] [Full Text] [Related]

  • 16. [Changes in the guanylate cyclase activity of human thrombocytes during ADP-inducible aggregation].
    Chirkov IuIu, Belushkina NN, Tyshchuk IA, Severina IS.
    Biull Eksp Biol Med; 1991 Feb; 111(2):152-4. PubMed ID: 1677293
    [Abstract] [Full Text] [Related]

  • 17. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS.
    Vestn Ross Akad Med Nauk; 1995 Feb; (2):41-6. PubMed ID: 7756930
    [Abstract] [Full Text] [Related]

  • 18. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM, Wu CC, Ko FN, Lee FY, Kuo SC.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):161-6. PubMed ID: 9059849
    [Abstract] [Full Text] [Related]

  • 19. Derivatives of 1,2-diazetidine-1,2-di-N-oxides--a new class of soluble guanylate cyclase activators with vasodilatory properties.
    Severina IS, Ryaposova IK, Volodarsky LB, Mozhuchin DC, Tichonov AYa, Schwartz GYa, Granik VG, Grigoryev DA, Grigoryev NB.
    Biochem Mol Biol Int; 1993 Jun 12; 30(2):357-66. PubMed ID: 8103389
    [Abstract] [Full Text] [Related]

  • 20. [The role of guanyl cyclase in the regulation of aggregation of human thrombocytes].
    Chirkov IuIu, Belushkina NN, Tyshchuk IA, Severina IS.
    Vestn Akad Med Nauk SSSR; 1991 Jun 12; (10):51-4. PubMed ID: 1686950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.